In the wake of the US Supreme Court’s recent overturn of Roe v. Wade, a 50-year-old decision by an earlier team of justices that guarantees women the right terminate a...
14.08.2018
- Perrigo has announced that its board of directors has approved a plan to separate its prescription pharmaceuticals (Rx) business, following a strategic portfolio review. Generic...
22.08.2017
- US buyout group SK Capital Partners has opted not to sell Archroma, announcing it has reinvested in the Swiss producer of textile chemicals, paper specialties and emulsions, which...
25.08.2016
- Canada-domiciled US drugmaker Valeant has appointed Paul Herendeen, former chief financial officer of Zoetis, to replace its own CFO, Robert Rosiello, as the company struggles to...
25.04.2016
- In its search for a new CEO to replace William J. Pearson, who has resigned amid several controversies, Canada-domiciled embattled drugmaker Valeant is said to be finalizing a...
15.02.2016
- On the rebound from its failed $27 billion hostile bid for Perrigo, Netherlands-domiciled, US-managed drugmaker Mylan has announced it will acquire Sweden’s Meda for 83.6 billion...
30.11.2015
- Drugs firms AstraZeneca and Sanofi are to exchange 210,000 compounds from their libraries to help boost their search for new small-molecule medicines. The companies have selected...
16.11.2015
- Mylan’s seven month-long, $26 billion long-shot hostile bid for Perrigo has ended in defeat for the Netherlands-based drugmaker. By the target deadline of Friday, Nov. 13, only 40%...
